Multiple myeloma: Looking beyond standards
Multiple myeloma has been regarded as an incurable disease with frequent relapses. The diagnostic criteria have been revised multiple times to include early stage of the disease where treatment can be effective and can prolong the survival. Newer diagnostic criteria for myeloma have incorporated ≥60...
Main Authors: | Esha Kaul, Sanjeev Kumar Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical Publishers, Inc.
2016-01-01
|
Series: | Asian Journal of Oncology |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.4103/2454-6798.180585 |
Similar Items
-
New Treatment Methods in Multiple Myeloma
by: Jakab Szende, et al.
Published: (2017-06-01) -
Bortezomib plus dexamethasone induction followed by autologous stem cell transplantation in multiple myeloma: A study from India
by: Jeevan Kumar
Published: (2016-07-01) -
Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma
by: Yutaka Tsukune, et al.
Published: (2019-11-01) -
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
by: Arthur Bobin, et al.
Published: (2020-10-01) -
Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art
by: Massimo Martino, et al.
Published: (2020-11-01)